Hantavirus cardiopulmonary syndrome

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 2, 2007, Pages 193-200

  Chang, Betty ^a   Crowley, Mark ^a   Campen, Matthew ^b   Koster, Frederick ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Cardiogenic shock; Extracorporeal membrane oxygenation; Hantavirus; Pulmonary edema; Thrombocytopenia

Indexed keywords

DOBUTAMINE; IMMUNOGLOBULIN; INFUSION FLUID; INOTROPIC AGENT; NORADRENALIN; RIBAVIRIN;

ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CAPILLARY LEAK SYNDROME; CARDIOGENIC SHOCK; CLINICAL FEATURE; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL OXYGENATION; FLUID RESUSCITATION; HANTAVIRUS; HUMAN; INCUBATION TIME; INTENSIVE CARE; LUNG EDEMA; LUNG HEMORRHAGE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH AMERICA; SURVIVAL TIME; THROMBOCYTOPENIA; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION;

ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; ZOONOSES;

EID: 34247574313     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-976491     Document Type: Article

References (68)

1. Koster F, Levy H. Hantavirus cardiopulmonary syndrome: a new twist to an established pathogen. In: Fong IW, Alibek K, eds. New and Evolving Infections of the 21st Century. New York: Kluwers Academic/Plenum Publishers; 2006:151-170
2. Mertz GJ, Hjelle B, Crowley MR, Iwamoto G, Tomicic V, Vial CP. Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis 2006;19:437-442
3. Khaiboullina SF, Morzunov S, St Jeor SC. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 2005;5:773-790
4. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a novel hantavirus associated with an outbreak of acute respiratory illness in the Southwestern United States. Science 1993;262:914-917
5. Figueiredo LTM, Moreli ML, Campos GM, Sousa RLM. Hantaviruses in Sao Paulo State, Brazil. Emerg Infect Dis 2003;9:891-892
6. Rosa ES, Mills JN, Padula PJ, et al. Newly recognized hantaviruses associated with hantavirus pulmonary syndrome in northern Brazil: partial genetic characterization of viruses and serologic implication of likely reservoirs. Vector Borne Zoonotic Dis 2005;5:11-19
7. Levis S, Garcia J, Pini N, et al. Hantavirus pulmonary syndrome in northwestern Argentina: circulation of Laguna Negra virus associated with Calomys callosus. Am J Trop Med Hyg 2004;71:658-663
8. Schmaljohn CS. Molecular biology of hantaviruses. In: Elliott RM, ed. The Bunyaviridae. New York: Plenum Press; 1996:63-86
9. Tsai TF. Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab Anim Sci 1987;37:428-430
10. Yates T, Mills JN, Parmenter CA, et al. The ecology and evolutionary history of an emergent disease: hantavirus pulmonary syndrome. BioScience 2002;52:989-998
11. Hjelle B, Torrez-Martinez N, Koster FT, et al. Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndrome. J Infect Dis 1996;173:781-786
12. Douglass RJ, Kuenzi AJ, Williams CY, Douglass SJ, Mills JN. Removing deer mice from buildings and the risk for human exposure to Sin Nombre virus. Emerg Infect Dis 2003;9:390-392
13. CDC. Hantavirus pulmonary syndrome-United States: updated recommendations for risk reduction. MMWR Recomm Rep 2002;51(RR-9):1-13
14. Vitek CR, Breiman RF, Ksiazek TG, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996;22:824-826
15. Wells RM, Young JC, Williams RJ, et al. Hantavirus transmission in the United States. Emerg Infect Dis 1997;3:361-365
16. Enria D, Padula P, Segura EL, et al. Hantavirus pulmonary syndrome in Argentina: possibility of person to person transmission. Medicina (B Aires) 1996;56:709-711
17. Martinez VP, Bellomo C, San Juan J, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 2005;11:1848-1853
18. Toro J, Vega JD, Khan AS, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 1998;4:687-694
19. Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B. Sin Nombre viral RNA load in patients with the hantavirus cardiopulmonary syndrome. J Infect Dis 2006;194:1403-1409
20. Xu ZY, Guo CS, Wu YL, Zhang XW, Liu K. Epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission. J Infect Dis 1985;152:137-144
21. St. Jeor SC. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J 2004;23:974-975
22. Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 cases. J Infect Dis 1996;173:1297-1303
23. Young JC, Hansen GR, Graves TK, et al. The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg 2000;62:714-717
24. Vial PA, Valdivieso F, Mertz G, et al. Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis 2006;12:1271-1273
25. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-955
26. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996;24:252-258
27. Koster F, Foucar K, Hjelle B, et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 2001;116:665-672
28. Zavasky DM, Hjelle B, Peterson MC, Denton RW, Reimer L. Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis 1999;29:664-666
29. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 1994;191:665-668
30. Riquelme R, Riquelme M, Torres A, et al. Hantavirus pulmonary syndrome, Southern Chile. Emerg Infect Dis 2003;9:1438-1443
31. Peterson MC, Bastian BV, Tatton JA. Radiologic findings of the hantavirus pulmonary syndrome. West J Med 1996;164:76-77
32. Boroja M, Barrie JR, Raymond GS. Radiographic findings in 20 patients with hantavirus pulmonary syndrome correlated with clinical outcome. AJR Am J Roentgenol 2002;178:159-163
33. Ketai LH, Kelsey CA, Jordan K, et al. Distinguishing hantavirus pulmonary syndrome from acute respiratory distress syndrome by chest radiography: are there different radiographic manifestations of increased alveolar permeability? J Thorac Imaging 1998;13:172-177
34. Hjelle B, Jenison S, Torrez-Martinez N, et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 1997;35:600-608
35. Zaki SR, Khan AS, Goodman RA, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. Arch Pathol Lab Med 1996;120:134-139
36. Hjelle B. Virus detection and identification with genetic tests. In: Lee HW, Calisher CH, Schmaljohn CS, eds. Manual of Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome. Seoul: WHO Collaborating Center for Virus Reference and Research (Hantaviruses); 1999:132-137
37. Ramos MM, Overturf G, Crowley MR, Rosenberg RB, Hjelle B. Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents. Pediatrics 2001;108:E27
38. Pai RK, Bharadwaj M, Levy H, et al. Absence of infection of a neonate after possible exposure to Sin Nombre hantavirus in breast milk. Clin Infect Dis 1999;29:1577-1579
39. Levy H, Simpson SQ. Hantavirus pulmonary syndrome. Am J Respir Crit Care Med 1994;149:1710-1713
40. Crowley MR, Katz RW, Kessler R, et al. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 1998;26:409-414
41. Rosenberg RB, Waagner DC, Romano MJ, Kanase HN, Young RB. Hantavirus pulmonary syndrome treated with inhaled nitric oxide. Pediatr Infect Dis J 1998;17:749-752
42. Adhikari N, Granton JT. Inhaled nitric oxide for acute lung injury: no place for NO? JAMA 2004;291:1629-1631
43. Hickman-Davis JM, McNicholas-Bevensee CM, Davis IC, et al. Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. Am J Respir Crit Care Med 2006;173:334-344
44. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-1127
45. Mertz GJ, Miedzinski L, Goade D, et al. Placebo-controlled, double blind trial of intravenous ribavirin for hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004;39:1307-1313
46. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000;182:43-48
47. Valdivieso F, Vial CP, Ferres MG, et al. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg Infect Dis 2006;12:166-168
48. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 1995;146:552-579
49. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995;26:110-120
50. Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect Dis 1998;177:1696-1700
51. Sundstrom JB, McMullan LK, Spiropoulou CF, et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 2001;75:6070-6085
52. Khaiboullina SF, Netski DM, Krumpe P, St. Jeor SC. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J Virol 2000;74:11966-11971
53. Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, Morikawa S. Modifications of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of Hantaan virus-infected endothelial cell monolayers. Arch Virol 2004;149:1279-1292
54. Khaiboullina SF, Rizvanov AA, Otteson E, Miyazato A, Maciejewski J, St. Jeor SC. Regulation of cellular gene expression in endothelial cells by Sin Nombre and prospect hill viruses. Viral Immunol 2004;17:234-251
55. Kraus AA, Raftery MJ, Giese T, et al. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 2004;78:6143-6150
56. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 2002;99:13837-13842
57. Terajima M, Hendershot JD III, Kariwa H, et al. High levels of viremia in patients with the hantavirus pulmonary syndrome. J Infect Dis 1999;180:2030-2034
58. Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 2002;147:1913-1931
59. Raymond T, Gorbunova E, Gavrilovskaya IN, Mackow ER. Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent αVβ3 integrin conformers. Proc Natl Acad Sci USA 2005;102:1163-1168
60. 3-integrin receptor. J Virol 2005;79:7319-7326
61. Mori M, Rothman AL, Kurane I, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999;179:295-302
62. Kilpatrick ED, Terajima M, Koster F, Catalina MD, Ennis FA. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004;172:3297-3304
63. Botten J, Mirowsky K, Kusewitt D, et al. Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci USA 2000;97:10578-10583
64. McElroy AK, Bray M, Reed DS, Schmaljohn CS. Andes virus infection of cynomolgus macaques. J Infect Dis 2002;186:1706-1712
65. Hooper JW, Custer DM, Smith J, Wahl-Jensen V. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 2006;347:208-216
66. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001;289:6-14
67. Milazzo ML, Eyzaguirre EJ, Molina CP, Fulhorst CF. Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome. J Infect Dis 2002;186:1390-1395
68. Campen MJ, Milazzo ML, Fulhorst CF, Obot Akata CJ, Koster F. Characterization of shock in a hamster model of hantavirus infection. Virology 2006;356:45-49